Impact of Lateral Bone Grafting With Intraoperative Fusion in ACDF on Clinical Outcomes

NCT06027827 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2023-09-07

No results posted yet for this study

Summary

The purpose of this trial was to investigate the safety and efficacy of fuser lateral bone grafting in ACDF. By observing the intervertebral bony fusion rate and clinical outcome scores of patients after fusion device lateral bone grafting, it was verified whether the fusion device lateral bone grafting approach could improve the bony fusion rate and clinical outcome of ACDF.

Conditions

  • Cervical Spondylosis

Interventions

PROCEDURE

Addition of fusion device lateral bone graft

In addition to the central bone graft of the fusion cage, the lateral bone graft of the fusion cage was added.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Fengzeng Jian, MD, PhD · Xuanwu Hospital, Beijing

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06027827 on ClinicalTrials.gov